Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rudy Schreiber

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 10, 2002
Role of 5-hT2C receptors in the hypophagic effect of m-CPP, ORG 37684 and CP-94,253 in the ratRudy Schreiber, Jean De Vry
Neurobiology of Learning and Memory|January 16, 2014
Improving cognition in schizophrenia with antipsychotics that elicit neurogenesis through 5-HT(1A) receptor activationRudy Schreiber, Adrian Newman-Tancredi
Current Neuropharmacology|October 30, 2019
A Mechanistic Rationale for PDE-4 Inhibitors to Treat Residual Cognitive Deficits in Acquired Brain InjuryRudy Schreiber, Romain Hollands, Arjan Blokland
Neurobiology of Learning and Memory|May 28, 2021
Improving cognitive functioning in major depressive disorder with psychedelics: A dimensional approachIgor Magaraggia, Zilla Kuiperes, Rudy Schreiber
Psychopharmacology|February 28, 2002
Effects of alpha 4/beta 2- and alpha 7-nicotine acetylcholine receptor agonists on prepulse inhibition of the acoustic startle response in rats and miceRudy Schreiber, Marion Dalmus, Jean De Vry
Current Opinion in Investigational Drugs (London, England : 2000)|June 24, 2010
Cognitive effects of muscarinic M1 functional agonists in non-human primates and clinical trialsRobert A McArthur, Julian Gray, Rudy Schreiber
Behavioural Brain Research|November 6, 2012
Motor, emotional and cognitive deficits in adult BACHD mice: a model for Huntington's diseaseYah-se K Abada, Rudy Schreiber, Bart Ellenbroek
International Journal of Environmental Research and Public Health|July 29, 2023
Examining the Psychoactive Differences between Kratom StrainsGuido Huisman, Maximilian Menke, Oliver Grundmann, et al.
European Journal of Pharmacology|January 8, 2004
Behavioral mechanisms underlying inhibition of food-maintained responding by the cannabinoid receptor antagonist/inverse agonist SR141716AJean De Vry, Rudy Schreiber, Gisela Eckel, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 10, 2023
The pathophysiology of Post SSRI Sexual Dysfunction - Lessons from a case studySamantha Klaas, Jessica Barbut Siva, Maarten Bak, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 10, 2002
Role of 5-hT2C receptors in the hypophagic effect of m-CPP, ORG 37684 and CP-94,253 in the ratRudy Schreiber, Jean De Vry
Neurobiology of Learning and Memory|January 16, 2014
Improving cognition in schizophrenia with antipsychotics that elicit neurogenesis through 5-HT(1A) receptor activationRudy Schreiber, Adrian Newman-Tancredi
Current Neuropharmacology|October 30, 2019
A Mechanistic Rationale for PDE-4 Inhibitors to Treat Residual Cognitive Deficits in Acquired Brain InjuryRudy Schreiber, Romain Hollands, Arjan Blokland
Neurobiology of Learning and Memory|May 28, 2021
Improving cognitive functioning in major depressive disorder with psychedelics: A dimensional approachIgor Magaraggia, Zilla Kuiperes, Rudy Schreiber
Psychopharmacology|February 28, 2002
Effects of alpha 4/beta 2- and alpha 7-nicotine acetylcholine receptor agonists on prepulse inhibition of the acoustic startle response in rats and miceRudy Schreiber, Marion Dalmus, Jean De Vry
Current Opinion in Investigational Drugs (London, England : 2000)|June 24, 2010
Cognitive effects of muscarinic M1 functional agonists in non-human primates and clinical trialsRobert A McArthur, Julian Gray, Rudy Schreiber
Behavioural Brain Research|November 6, 2012
Motor, emotional and cognitive deficits in adult BACHD mice: a model for Huntington's diseaseYah-se K Abada, Rudy Schreiber, Bart Ellenbroek
International Journal of Environmental Research and Public Health|July 29, 2023
Examining the Psychoactive Differences between Kratom StrainsGuido Huisman, Maximilian Menke, Oliver Grundmann, et al.
European Journal of Pharmacology|January 8, 2004
Behavioral mechanisms underlying inhibition of food-maintained responding by the cannabinoid receptor antagonist/inverse agonist SR141716AJean De Vry, Rudy Schreiber, Gisela Eckel, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 10, 2023
The pathophysiology of Post SSRI Sexual Dysfunction - Lessons from a case studySamantha Klaas, Jessica Barbut Siva, Maarten Bak, et al.
Pageof 5